Literature DB >> 22803382

[Effect of different compatibility of tetramethylpyrazine on its pharmacokinetics in vivo].

Binbin Feng1, Jianhai Zhang, Jifen Zhang, Gang Chen, Xiaoyu Xu.   

Abstract

OBJECTIVE: To study the pharmacokinetics of single administration and different compatibility of tetramethylpyrazine (TMP) in rats.
METHOD: Thirty two Sprague-Dawley rats were randomly divided into 4 groups: the TMP (30 mg x kg(-1)) group, the TMP+FA (30 mg x kg(-1) + 50 mg x kg(-1)) group, the TMP+TET (30 mg x kg(-1) mg x kg(-1)) group and the TMP+FA+TET (30 mg x kg(-1) + 50 mg x kg(-1) + 20 mg x kg(-1)) group. After the oral administration, their blood samples were collected to detect plasmas concentrations by HPLC method and to calculate pharmacokinetic parameters DAS 2.0 program. RESULT: In compatibility with FA, AUC(0-t), Cmax and Tmax showed no significant difference with the single administration of TMP, but t(1/2) and MRT,, were obviously longer than the single administration. In compatibility with TET and FA + TET, AUC (0-t), Cmax and Tmax showed significant increase than the single administration of TMP, whereas t(1/2) and MRT0, did not notably vary from the single administration.
CONCLUSION: FA can prolong TMP's action time in rats, and TET can accelerate TMP's absorption in rats.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22803382

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  2 in total

1.  Pharmacokinetic Profiling of Butylidenephthalide and Alisol B in Danggui-Shaoyao-San in Rats.

Authors:  Hui-Fei Wu; Xiang-Yu Wang; Ji-Feng Deng; Shi-Jian Quan; Qi Wang; Wei-Rong Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-12       Impact factor: 2.441

2.  Exploring the Scientific Rationality of the Phenomenon of "Different Dosage Forms of the Same Prescription" of Chinese Proprietary Medicine Based on Biopharmaceutical Properties of Powder and Pill of Chuanxiong Chatiao Prescription.

Authors:  Zhong-Huan Qu; Lin Liu; Xiao-Fei Zhang; Dong-Yan Guo; Bing-Tao Zhai; Jun-Bo Zou; Ya-Jun Shi
Journal:  Front Pharmacol       Date:  2022-06-09       Impact factor: 5.988

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.